Literature DB >> 12244153

Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen.

Amy D Higgins1, Marianne A Mihalyo, Adam J Adler.   

Abstract

It has long been established that exposure of naive T cells to specific Ag in the absence of adjuvant leads to tolerization. Nonetheless, the potential of effector CD4 cells to be tolerized has been less well characterized. To address this issue, we have used an adoptive transfer system in which naive TCR transgenic hemagglutinin (HA)-specific CD4(+) T cells are initially primed to express effector function upon exposure to an immunogenic recombinant vaccinia virus expressing HA, and then exposed to forms of HA that are tolerogenic for naive CD4 cells. HA-specific effector CD4 cells residing in both the spleen as well as in two separate nonlymphoid tissues were tolerized upon exposure to high doses of exogenous soluble HA peptide. Additionally, tolerance could also be induced by bone marrow-derived APCs that cross-present parenchymally derived self-HA. Thus, effector CD4 cells are susceptible to similar tolerogenic stimuli as are naive CD4 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12244153      PMCID: PMC2855047          DOI: 10.4049/jimmunol.169.7.3622

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Activation of low avidity CTL specific for a self epitope results in tumor rejection but not autoimmunity.

Authors:  D J Morgan; H T Kreuwel; S Fleck; H I Levitsky; D M Pardoll; L A Sherman
Journal:  J Immunol       Date:  1998-01-15       Impact factor: 5.422

2.  The duration of antigenic stimulation determines the fate of naive and effector T cells.

Authors:  G Iezzi; K Karjalainen; A Lanzavecchia
Journal:  Immunity       Date:  1998-01       Impact factor: 31.745

Review 3.  Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.

Authors:  R Liblau; R Tisch; N Bercovici; H O McDevitt
Journal:  Immunol Today       Date:  1997-12

4.  Naive and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals.

Authors:  C Dubey; M Croft; S L Swain
Journal:  J Immunol       Date:  1996-10-15       Impact factor: 5.422

5.  Differential requirements for survival and proliferation of CD8 naïve or memory T cells.

Authors:  C Tanchot; F A Lemonnier; B Pérarnau; A A Freitas; B Rocha
Journal:  Science       Date:  1997-06-27       Impact factor: 47.728

6.  Constitutive class I-restricted exogenous presentation of self antigens in vivo.

Authors:  C Kurts; W R Heath; F R Carbone; J Allison; J F Miller; H Kosaka
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

7.  Differential T cell receptor-mediated signaling in naive and memory CD4 T cells.

Authors:  D L Farber; O Acuto; K Bottomly
Journal:  Eur J Immunol       Date:  1997-08       Impact factor: 5.532

8.  Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis.

Authors:  R S Liblau; R Tisch; K Shokat; X Yang; N Dumont; C C Goodnow; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

Review 9.  Prospects for adoptive T cell therapy.

Authors:  C Yee; S R Riddell; P D Greenberg
Journal:  Curr Opin Immunol       Date:  1997-10       Impact factor: 7.486

10.  Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.

Authors:  D E Speiser; R Miranda; A Zakarian; M F Bachmann; K McKall-Faienza; B Odermatt; D Hanahan; R M Zinkernagel; P S Ohashi
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

View more
  16 in total

1.  Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector function.

Authors:  Amy D H Doody; Joseph T Kovalchin; Marianne A Mihalyo; Adam T Hagymasi; Charles G Drake; Adam J Adler
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

2.  T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expression.

Authors:  Meixiao Long; Aaron M Slaiby; Adam T Hagymasi; Marianne A Mihalyo; Alexander C Lichtler; Steven L Reiner; Adam J Adler
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

3.  Tolerization of an established alphaB-crystallin-reactive T-cell response by intravenous antigen.

Authors:  Richard Verbeek; Koen van der Mark; Eric F Wawrousek; Arianne C Plomp; Johannes M van Noort
Journal:  Immunology       Date:  2007-04-26       Impact factor: 7.397

4.  Dendritic cells program non-immunogenic prostate-specific T cell responses beginning at early stages of prostate tumorigenesis.

Authors:  Marianne A Mihalyo; Adam T Hagymasi; Aaron M Slaiby; Erin E Nevius; Adam J Adler
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

5.  Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells.

Authors:  Adam T Hagymasi; Aaron M Slaiby; Marianne A Mihalyo; Harry Z Qui; David J Zammit; Leo Lefrancois; Adam J Adler
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

6.  Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Authors:  Charles G Drake; Amy D H Doody; Marianne A Mihalyo; Ching-Tai Huang; Erin Kelleher; Sowmya Ravi; Edward L Hipkiss; Dallas B Flies; Eugene P Kennedy; Meixiao Long; Patrick W McGary; Lee Coryell; William G Nelson; Drew M Pardoll; Adam J Adler
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

7.  Costimulation Induces CD4 T Cell Antitumor Immunity via an Innate-like Mechanism.

Authors:  Crystal Morales Del Valle; Joseph R Maxwell; Maria M Xu; Antoine Menoret; Payal Mittal; Naomi Tsurutani; Adam J Adler; Anthony T Vella
Journal:  Cell Rep       Date:  2019-04-30       Impact factor: 9.423

8.  In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.

Authors:  Marianne A Mihalyo; Amy D H Doody; Jeremy P McAleer; Elizabeth C Nowak; Meixiao Long; Yi Yang; Adam J Adler
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

9.  Effector CD4 cell tolerization is mediated through functional inactivation and involves preferential impairment of TNF-alpha and IFN-gamma expression potentials.

Authors:  Meixiao Long; Amy D Higgins; Marianne A Mihalyo; Adam J Adler
Journal:  Cell Immunol       Date:  2003-08       Impact factor: 4.868

10.  Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen.

Authors:  Meixiao Long; Aaron M Slaiby; Shuang Wu; Adam T Hagymasi; Marianne A Mihalyo; Suman Bandyopadhyay; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.